Theravance Biopharma Inc
USD16.84
+0.03 (+0.18%)
CEO
Rick E. Winningham
IPO Date
2014-05-16
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Country
US
Open
$16.88
Prev. Close
$16.81
Day Low
$16.84
Day High
$16.90
52W Low
$10.82
52W High
$21.03
Market Cap
$0.87B
Volume
0.84M
| 3,329 |
| $16.39 |
| 17 Jun 2026 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S-Sale | Disposed | 3,328 | $16.38 |
| 17 Jun 2026 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S-Sale | Disposed | 6,657 | $16.39 |
| 16 Jun 2026 | Smaldone Alsup Laurie | director | A-Award | Acquired | 6,009 | $0.00 |
| 16 Jun 2026 | Smaldone Alsup Laurie | director | A-Award | Acquired | 13,398 | $16.64 |
| 16 Jun 2026 | GRAY SUSANNAH | director | A-Award | Acquired | 6,009 | $0.00 |
| 16 Jun 2026 | GRAY SUSANNAH | director | A-Award | Acquired | 13,398 | $16.64 |
| 16 Jun 2026 | MITCHELL DEAN J | director | A-Award | Acquired | 6,009 | $0.00 |
| 16 Jun 2026 | MITCHELL DEAN J | director | A-Award | Acquired | 13,398 | $16.64 |